GSK-3 inhibitor XIII   Click here for help

GtoPdb Ligand ID: 5976

Synonyms: K00244
PDB Ligand
Compound class: Synthetic organic
Comment: This is compound 3 in [2].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 4
Hydrogen bond donors 2
Rotatable bonds 3
Topological polar surface area 66.49
Molecular weight 301.13
XLogP 4.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES Cc1[nH]nc(c1)Nc1nc(nc2c1cccc2)c1ccccc1
Isomeric SMILES Cc1[nH]nc(c1)Nc1nc(nc2c1cccc2)c1ccccc1
InChI InChI=1S/C18H15N5/c1-12-11-16(23-22-12)20-18-14-9-5-6-10-15(14)19-17(21-18)13-7-3-2-4-8-13/h2-11H,1H3,(H2,19,20,21,22,23)
InChI Key JYCUVOXSZBECAY-UHFFFAOYSA-N
References
1. Anastassiadis T, Deacon SW, Devarajan K, Ma H, Peterson JR. (2011)
Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity.
Nat Biotechnol, 29 (11): 1039-45. [PMID:22037377]
2. Bebbington D, Binch H, Charrier JD, Everitt S, Fraysse D, Golec J, Kay D, Knegtel R, Mak C, Mazzei F et al.. (2009)
The discovery of the potent aurora inhibitor MK-0457 (VX-680).
Bioorg Med Chem Lett, 19 (13): 3586-92. [PMID:19447622]
3. Gao Y, Davies SP, Augustin M, Woodward A, Patel UA, Kovelman R, Harvey KJ. (2013)
A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
Biochem J, 451 (2): 313-28. [PMID:23398362]